Loading...
Symbols:
Loading...
Symbols:
Sinovac Biotech Ltd. (SVA)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Sinovac Biotech Ltd. (SVA)
37 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on SVA
Most popular authors
(tracked in watchlists)
Most commented on authors
- Sales of Sinovac's Hepatitis Vaccine Suspended Following Baby's Death
- China Biopharma News Back in the Spotlight
- China Bio in Review: More Fallout from Economic Crisis
- Sinovac Listed in Deloitte Technology Fast 50 China 2008
- China Biotech in Review: Deals, Developments and Financials
- Sinovac to Develop Hand, Foot and Mouth Disease Vaccine
- China Biotech in Review: A Designated Hotspot
- Sinovac Strikes Deal for Hepatitis Vaccine Trials in the Ukraine
- China Biopharma Week in Review: Broad Views, Individual Companies
- Sinovac Launches New Version of Flu Vaccine
- China Biotech Week in Review: Earnings, Earnings, Earnings
- Sinovac Q2 Revenues Climb 73%
- China Biomedical Industry Evolving
- Sinovac Starts Phase II Trial of Pandemic Flu Vaccine
- China Biotech Week in Review: Deals and Drugs
- Sinovac Delivers 80,000 Vaccine Doses to Earthquake Victims
- China Biotech Week in Review: Earnings, Deals and Drug Development
- Sinovac to Supply Vaccines to China Earthquake Victims
- China Biopharma Growth Metrics
- Sinovac’s Q1 Doubles Year-Earlier Results
- Downturn in China Biotech Stocks Shows No Impact on Activity
- Sinovac Reports 118% Revenue Growth for 2007
- The Week in Review: China Biopharma Investing Pays Off
- Sinovac Biotech on a Corporate Upswing
- China Biotech Week in Review: East-West Interdependence in 2007
- Sinovac Reports Success with Bird Flu Vaccine
- China Biotech Week in Review: Safety Regulation Improves
- Sinovac's Vaccines on a Roll
- Chinese Stocks Just Getting Started? Two Opportunities
- Sinovac Starts Next Phase In Pandemic Flu Vaccine Trial
- Sinovac Almost Triples Revenue in First Half
- Sinovac To Co-Promote Flu Vaccine With GlaxoSmithKline, Seeks Additional Partnerships
- Sinovac Biotech Begins Phase II Test of Bird Flu Vaccine
- Sinovac: Positive Opportunities Arise from Recent Material Improvement
- China Heating Up: Venture Capital, Halter Index Soar
-
Stock Pick #2: Sinovac Biotech (SVA)
on Dec 07, 2005
-
China Book Giveaway: Winners and China Stock Recommendations (CNTF, SVA, SINA, ADIY, FMCN)
on Dec 07, 2005
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »